Sources | Names Used |
---|---|
CTRPv2 | selumetinib:BRD-A02303741 (4:1 mol/mol) |
PharmacoGx | selumetinib:BRD-A02303741 (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HNMT | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
mRNA | ASB3 | CTRPv2 | pan-cancer | AAC | -0.2 | 5e-08 |
mRNA | C16orf59 | CTRPv2 | pan-cancer | AAC | -0.2 | 5e-08 |
mRNA | RP11-762I7.5 | CTRPv2 | pan-cancer | AAC | -0.2 | 5e-08 |
mRNA | SKA1 | CTRPv2 | pan-cancer | AAC | -0.2 | 6e-08 |
mRNA | SARNP | CTRPv2 | pan-cancer | AAC | -0.2 | 6e-08 |
mRNA | ABHD14A-ACY1 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-08 |
mRNA | DHX32 | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-08 |
mRNA | SPECC1L | CTRPv2 | pan-cancer | AAC | -0.19 | 7e-08 |
mRNA | PRR3 | CTRPv2 | pan-cancer | AAC | -0.22 | 7e-08 |